// App-Quantinova.ai

2019 : SOX2 silencing upregulates CDKN1A and suppresses growth of lung squamous cell carcinoma

Researchers

Presenter

  • Takuya Fukazawa

Principal Investigators

  • Tomokoki Yamatsuji

  • Munenori Takaoka

  • Etsuko Yokota

  • Minoru Haisa

  • Naomasa Ishida

  • Masakazu Yoshida

  • Noriko Miyake

  • Nagio Takigawa

  • Yutaka Maeda

  • Yoshio Naomoto

Medical Centers

  • Kawasaki Medical School, Okayama, Japan

  • Kawasaki Hospital Research Unit, Okayama, Japan

  • Cincinnati Children's Hospital Medical Center, Cincinnati, OH

Locations

  • United States

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lung Cancer

  • Non Small Cell Lung cancer

  • Squamous cell carcinoma

  • Small cell lung cancer

  • Solid malignancies

Biomarkers

  • Cyclin dependent kinase inhibitor 1A

  • Serpin B3

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved